[ad_1]
DUBLIN – (FILO D & # 39; BUSINESS) –
This report presents an extensive study of the players in the sector they are
offering blockchain platforms for genomic storage and management
data.
The success of the Human Genome Project has led to the generation of
large volumes of genomic data, which are widely used in
biotechnology and medical research. Also, progress up
sequencing technologies of throughput genes have enabled scientists to
accelerate the process of genome sequencing and achieve significant costs
Benefits as well. Indeed, it is estimated that, by 2025, around 15%
of the world's population will have sequenced their genomes,
resulting in the generation of several zettabytes of data.
However, at the moment, there are not many reliable and reliable data
management resources that offer secure storage, seamless exchange of
information and a reliable transaction platform for large volumes of
genomic and clinical data. Therefore, at this stage, it has become
It is important to develop and establish the necessary tools and technologies
effectively help with the processing and analysis of the
information above and to make it easily accessible to
practicing doctors, scientists, pharmaceutical companies and more
interested parties.
Blockchain technology has emerged as a viable option for
memorize / exchange genomic data. Decentralized information management
the model used in blockchains has shown significant advantages in
banking and fintech sector. Furthermore, cryptocurrencies, which are
based on blockchain technology, they are considered a powerful tool
for peer-to-peer transactions without involving third parties to track
the exchange.
In the field of genomics, blockchain can act as a means of trust
make transactions between data owners and data users (search
pharmaceutical groups / companies). Moreover, such platforms allow for easy
access to genomic data sets, therefore, significantly improving the
information acquisition process for research studies related to
medicines / personalized therapies.
As a result, many companies have taken steps to promote the
use of blockchain technology for the management of genomic data. In fact, the
growing importance of the blockchain for the management of genetic information e
using it in health decision making is also evident in the number of
tweets (~ 1.750) published on the social media platform, Twitter, in
recent years.
In recent years, recent activities in this area, such as
establishment of strategic partnerships (involving pharmaceuticals)
players and competent government bodies) and investments per company
capital / other interested parties, indicate that the concept of use
blockchain platforms for the storage and management of genetics
information is gaining ground in the health sector. We believe
that these efforts could promote the overall growth of this market
in the years to come.
Main topics covered
1. Preface
2. Executive summary
3. Introduction
4. Panorama of the market
5. Company profiles
6. Emerging trends on social media
7. Analysis of the needs of the parties involved
8. Go-To-Market Strategy
9. Analysis of market capitalization
10. Blockchain in Genomic Data Management: use cases and opportunities
Rating
11. Analysis of recent trends
12. Executive deepenings
Featured companies
-
23andMe
-
Ancestry
-
Anorak Ventures
-
ARCH Venture Partners
-
BIGSTER
-
Biologix Group
-
Block23
-
Increase VC
-
Bridge Link Capital
-
eMQT
-
Emrify
-
EncrypGen
-
Enigma Technologies
-
The capital of Fenbushi
-
Gene BlockChain
-
Genomes.io
-
Wizz health
-
Heartbeat Labs
-
Hemi Ventures
-
Hemisphere Ventures
-
Hikma Ventures
-
Capital of Hoperidge
-
Illumina Ventures
-
Ironside Capital
-
Khosla Ventures
-
Longenesis
-
Genomic Nebula
-
Shivom
-
SimplyVital Health
-
SingularityNET
-
Spherity
-
X Genomics
-
Fund for the innovation of the IOG
-
Zenome
-
and many others…
For more information on this report, visit https://www.researchandmarkets.com/research/5kmdk5/blockchain_in?w=4
